The O
results O
further O
demonstrated O
the O
activation O
of O
S6 B
kinase I
( O
pp90rsk B
) O
, O
evidenced O
by O
phosphorylation O
of O
S6 B
and O
serum O
response O
factor O
( O
SRF O
) O
peptides O
, O
in O
PWM O
treated O
B O
cells O
. O

They O
also O
display O
constitutively O
high O
levels O
of O
p59fyn B
and O
CD3 B
zeta I
tyrosine O
phosphorylation O
. O

Transient O
transfections O
using O
reporter B
constructs I
with O
multiples O
of O
transcription B
factor I
binding I
sites I
from O
the O
IL B
- I
2 I
promoter I
[ O
distal B
nuclear I
factor I
( I
NF I
) I
- I
AT I
, O
proximal B
NF I
- I
AT I
, O
AP B
- I
1 I
/ I
Octamer I
( O
UPS B
) O
or O
NF B
- I
chi I
B I
( O
TCEd B
) O
sites O
] O
were O
performed O
. O

Does O
thyroidectomy O
, O
radioactive O
iodine O
therapy O
, O
or O
antithyroid O
drug O
treatment O
alter O
reactivity O
of O
patients O
' O
T O
cells O
to O
epitopes O
of O
thyrotropin B
receptor I
in O
autoimmune O
thyroid O
diseases O
? O

The O
incubation O
with O
transforming B
growth I
factor I
beta I
1 I
and O
1 O
alpha O
, O
25 O
- O
dihydroxyvitamin O
D3 O
resulted O
in O
a O
5 O
- O
to O
7 O
- O
fold O
increase O
of O
AhR B
mRNA I
. O

However O
, O
reagents O
such O
as O
nerve B
growth I
factor I
( O
NGF B
) O
and O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
which O
induce O
phenotypical O
differentiation O
of O
the O
SH O
- O
SY5Y O
neuroblastoma O
cell O
line O
, O
activated O
NF B
- I
kappa I
B I
, O
but O
only O
in O
that O
particular O
cell O
line O
. O

Full O
activation O
of O
the O
MAP B
kinases I
that O
phosphorylate O
the O
Jun B
activation I
domain I
, O
JNK1 B
and O
JNK2 B
, O
required O
costimulation O
of O
T O
cells O
with O
either O
TPA O
and O
Ca2 O
+ O
ionophore O
or O
antibodies O
to O
TCR B
and O
CD28 B
. O

The O
expression O
of O
the O
M B
- I
CSF I
gene I
, O
that O
has O
been O
recently O
reassigned O
to O
the O
short B
arm I
of I
chromosome I
1 I
( O
lp B
) O
, O
was O
also O
investigated O
. O

We O
therefore O
reexamined O
this O
issue O
by O
using O
two O
different O
experimental O
approaches O
that O
allowed O
LMP1 B
- O
induced O
effects O
to O
be O
monitored O
immediately O
following O
expression O
of O
the O
viral O
protein O
and O
in O
the O
absence O
of O
selective O
pressures O
; O
activation O
of O
the O
NF B
- I
kappa I
B I
transcription B
factor I
and O
upregulation O
of O
the O
cell B
adhesion I
molecule I
ICAM B
- I
1 I
were O
used O
as O
early O
indices O
of O
LMP1 B
function O
. O

NH2 B
- O
terminal O
amino O
acid O
sequence O
analysis O
identified O
the O
140 B
- I
kDa I
surface I
antigen I
for O
mAb B
J393 I
as O
CD43 B
/ I
leukosialin I
, O
the O
major O
sialoglycoprotein B
of O
leukocytes O
. O

The O
protein B
- I
tyrosine I
kinase I
ZAP B
- I
70 I
is O
implicated O
, O
together O
with O
the O
Src B
kinase I
p56 B
( I
lck I
) I
, O
in O
controlling O
the O
early O
steps O
of O
the O
T O
- O
cell O
antigen O
receptor O
( O
TCR B
) O
signaling O
cascade O
. O

ORF1 B
consists O
of O
240 O
bp O
that O
would O
encode O
80 O
amino O
acids O
, O
while O
the O
major B
ORF2 I
consists O
of O
648 O
bp O
capable O
of O
coding O
for O
216 O
amino O
acids O
. O

Here O
, O
we O
report O
that O
differentiated O
B O
cells O
contain O
a O
novel O
substoichiometric O
TAF B
of O
105 O
kDa O
not O
found O
associated O
with O
TFIID B
isolated O
from O
other O
cell O
types O
. O

MNDA B
( O
myeloid B
cell I
nuclear I
differentiation I
antigen I
) O
is O
an O
interferon B
alpha I
regulated I
nuclear I
protein I
expressed O
only O
in O
cells O
of O
the O
human O
myelomonocytic O
lineage O
. O

Using O
these O
T O
cells O
as O
a O
model O
of O
IL B
- I
12 I
signal O
transduction O
, O
we O
confirmed O
that O
these O
events O
involve O
members O
of O
the O
Janus B
kinase I
family I
of O
nonreceptor B
tyrosine I
kinases I
JAK2 B
, O
TYK2 B
, O
and O
signal B
transducer I
and I
activator I
of I
transcription I
4 I
. O

Expression O
of O
Retinoid B
X I
Receptor I
alpha I
is O
increased O
upon O
monocytic O
cell O
differentiation O
. O

In O
NB4 O
cells O
, O
two O
other O
synthetic O
nonselective O
RAR O
ligands O
are O
capable O
of O
inducing O
LAP B
as O
much O
as O
AM580 O
, O
whereas O
RAR O
beta O
- O
or O
RAR O
gamma O
- O
specific O
ligands O
are O
totally O
ineffective O
. O

Basement O
membrane O
immunoreactivity O
for O
type B
IV I
collagen I
and O
laminin B
was O
discontinuous O
in O
most O
examples O
of O
IDC O
regardless O
of O
type O
, O
with O
a O
trend O
toward O
more O
intense O
staining O
in O
comedo O
than O
in O
noncomedo O
carcinomas O
. O

Administration O
of O
megakaryocyte B
growth I
and I
development I
factor I
or O
interleukin B
6 I
could O
not O
overcome O
the O
differentiation O
block O
. O

In O
this O
study O
, O
we O
demonstrate O
that O
stress B
- I
activated I
protein I
kinases I
( O
SAPK B
) O
are O
activated O
after O
CD40 B
cross O
- O
linking O
on O
various O
B O
cell O
lines O
or O
human O
tonsillar O
B O
cells O
. O

In O
summary O
, O
CD40 B
signaling O
preferentially O
induces O
SAPK B
but O
not O
MAPK B
. O

Here O
we O
show O
that O
1alpha O
, O
25 O
( O
OH O
) O
2 O
- O
d5 O
- O
previtamin O
D3 O
( O
HF O
) O
, O
JN O
, O
KH1060 O
, O
and O
MC903 O
induce O
expression O
of O
PKC B
alpha I
and O
PKC B
delta I
and O
translocation O
of O
both O
isoforms O
to O
the O
particulate O
fraction O
, O
and O
PKC B
alpha I
to O
the O
nuclear O
fraction O
. O

Pertussis O
toxin O
, O
which O
ADP O
- O
ribosylates O
the O
Gi B
proteins I
known O
to O
couple O
to O
the O
C5a B
receptor I
, O
produced O
minimal O
inhibition O
of O
C5a O
- O
induced O
IL B
- I
8 I
expression O
and O
had O
little O
effect O
on O
C5a O
- O
induced O
calcium O
mobilization O
in O
RAW264 O
. O
7 O
cells O
. O

Additionally O
, O
virus O
reactivation O
in O
resting O
PBMCs O
infected O
in O
vitro O
with O
HIV O
- O
1 O
was O
found O
to O
be O
specifically O
induced O
by O
ligands O
of O
the O
CDR2 B
- I
loop I
in O
domain B
1 I
( O
D1 B
) O
of O
CD4 B
( O
virus B
envelope I
and I
anti I
- I
CD4 I
monoclonal I
antibodies I
) O
. O

In O
contrast O
, O
virus O
reactivation O
was O
not O
observed O
following O
CD4 B
oligomerization O
by O
antibodies B
that O
bind O
other O
epitopes O
in O
D1 B
, O
including O
the O
D1 B
/ I
CDR3 I
- I
loop I
. O

The O
effect O
of O
oestrogens O
on O
oestrogen O
- O
receptive O
organs O
and O
cells O
is O
mediated O
via O
intracellular B
receptors I
( O
ERalpha B
and O
ERbeta B
) O
. O

As2O3 O
induced O
PML O
( O
promyelocytic O
leukemia O
) O
protein O
degradation O
but O
did O
not O
modulate O
expression O
of O
cell B
cycle I
- I
related I
proteins I
, O
including O
c B
- I
myc I
, O
retinoblastoma B
protein I
, O
cyclin B
- I
dependent I
kinase I
4 I
, O
cyclin B
D1 I
, O
and O
p53 B
, O
or O
expression O
of O
differentiation B
- I
related I
antigens I
. O

The O
costimulatory B
molecule I
CD28 B
has O
a O
restricted O
tissue O
distribution O
and O
is O
expressed O
on O
T O
cells O
and O
some O
plasmacytoma O
cells O
. O

These O
include O
the O
Ikaros B
, O
LKLF B
, O
and O
GATA3 B
zinc I
- I
finger I
proteins I
; O
the O
Ets B
, O
CREB B
/ I
ATF I
, O
and O
NF B
- I
kappa I
B I
/ I
Rel I
/ I
NFAT I
transcription I
factors I
; O
the O
Stat B
proteins I
; O
and O
HMG B
box I
transcription I
factors I
such O
as O
LEF1 B
, O
TCF1 B
, O
and O
Sox4 B
. O

Epo B
caused O
an O
increase O
in O
the O
proportion O
of O
cells O
expressing O
cell O
surface O
glycophorin B
A I
( O
GPA B
) O
and O
up O
- O
regulated O
beta B
- I
and I
gamma I
- I
globin I
by O
several O
fold O
. O

We O
investigated O
the O
MAPk B
kinase I
( O
MKK B
) O
that O
activates O
p38 B
MAPk I
in O
response O
to O
LPS O
, O
the O
p38 B
MAPk I
isoforms I
that O
are O
activated O
as O
part O
of O
this O
pathway O
, O
and O
the O
functional O
responses O
affected O
by O
p38 B
MAPk I
activation O
. O

Although O
MKK3 B
, O
MKK4 B
, O
and O
MKK6 B
all O
activated O
p38 B
MAPk I
in O
experimental O
models O
, O
only O
MKK3 B
was O
found O
to O
activate O
recombinant O
p38 B
MAPk I
in O
LPS O
- O
treated O
neutrophils O
. O

Role O
of O
cellular B
tumor I
necrosis I
factor I
receptor I
- I
associated I
factors I
in O
NF B
- I
kappaB I
activation O
and O
lymphocyte O
transformation O
by O
herpesvirus O
Saimiri O
STP B
. O

LSF B
( O
also O
known O
as O
LBP B
- I
1 I
, O
UBP B
, O
and O
CP B
- I
2 I
) O
has O
been O
shown O
to O
repress O
LTR O
transcription O
in O
vitro O
, O
but O
transient O
expression O
of O
LSF B
has O
no O
effect O
on O
LTR B
activity O
in O
vivo O
. O

Here O
we O
report O
the O
induction O
of O
the O
synthesis O
and O
of O
the O
hydrolytic O
activity O
of O
phospholipase B
C I
gamma I
1 I
( O
PLC B
gamma I
1 I
) O
in O
human O
T O
lymphocytes O
by O
IFN B
- I
beta I
. O

The O
increased O
level O
of O
PLC B
gamma I
1 I
becomes O
evident O
after O
90 O
min O
of O
IFN B
- I
beta I
treatment O
and O
is O
still O
detectable O
after O
24 O
h O
. O

Neither O
the O
PLC B
gamma I
1 I
overexpression O
induced O
by O
IFN B
nor O
the O
increased O
hydrolytic O
activity O
of O
the O
enzyme B
appear O
to O
be O
affected O
by O
pretreatment O
of O
the O
cells O
with O
the O
protein O
tyrosine B
kinase I
inhibitor O
genistein O
, O
which O
is O
known O
to O
prevent O
the O
association O
of O
ISGF3 B
components O
. O

These O
results O
suggest O
that O
in O
human O
T O
lymphocytes O
IFN B
- I
beta I
can O
activate O
other O
transcription B
factor I
( O
s O
) O
distinct O
from O
ISGF3 B
to O
regulate O
PLC B
gamma I
1 I
expression O
. O

Ligand O
binding O
and O
activation O
of O
the O
IL B
- I
10 I
receptor I
expressed O
on O
B O
- O
CLL O
cells O
results O
in O
the O
phosphorylation O
of O
signal B
transducer I
and I
activator I
of I
transcription I
1 I
( O
STAT1 B
) O
and O
STAT3 B
proteins O
. O

CD28 B
is O
an O
important O
costimulatory B
molecule I
in O
the O
activation O
of O
human O
T O
cells O
. O

We O
show O
that O
ligand O
- O
induced O
homodimerization O
of O
chimeric B
surface I
receptors I
consisting O
of O
the O
extracellular B
and I
transmembrane I
domains I
of O
the O
erythropoietin B
receptor I
and O
of O
the O
intracellular B
domain I
of O
IL B
- I
4Ralpha I
induces O
Janus B
kinase I
1 I
( O
Jak1 B
) O
activation O
, O
STAT6 B
activation O
, O
and O
Cepsilon B
germline I
transcripts I
in O
human O
B O
cell O
line O
BJAB O
. O

V3 B
- I
BH10 I
neither O
blocked O
radiolabeled O
IL B
- I
2 I
binding O
to O
IL B
- I
2 I
receptors I
nor O
affected O
tyrosyl O
phosphorylation O
of O
several O
cellular B
proteins I
( O
p120 B
, O
p98 B
, O
p96 B
, O
p54 B
, O
and O
p38 B
) O
, O
which O
is O
immediately O
induced O
by O
IL B
- I
2 I
stimulation O
. O

An O
E2F B
- I
4 I
/ I
p130 I
complex I
was O
detected O
in O
representative O
samples O
of O
all O
FAB B
types O
analysed O
. O

In O
order O
to O
evaluate O
the O
conditions O
for O
optimal O
expression O
and O
immunogenicity O
of O
varicella B
- I
zoster I
virus I
( I
VZV I
) I
proteins I
in O
a O
herpes O
simplex O
virus O
- O
1 O
( O
HSV O
- O
1 O
) O
vector O
, O
we O
selected O
the O
VZV B
glycoprotein I
E I
( O
gE B
) O
, O
encoded O
by O
ORF B
68 I
and O
the O
VZV B
product I
of O
ORF B
62 I
, O
an O
immediate B
- I
early I
major I
tegument I
protein I
( O
IE62 B
) O
. O

NO O
is O
produced O
from O
at O
least O
three O
different O
NO B
synthase I
( I
NOS I
) I
isoforms I
: O
neuronal B
NOS I
( O
nNOS B
) O
, O
endothelial B
NOS I
, O
and O
immunologic B
NOS I
( O
iNOS B
) O
. O

The O
expression O
and O
binding O
activity O
of O
the O
Nfil3 B
protein I
( O
also O
called O
E4bp4 B
) O
, O
but O
not O
of O
Hlf B
, O
Dbp B
, O
or O
Tef B
, O
was O
found O
to O
be O
regulated O
by O
IL B
- I
3 I
in O
mouse O
pro O
- O
B O
cell O
lines O
( O
Baf O
- O
3 O
and O
FL5 O
. O
12 O
) O
. O

The O
gene O
encodes O
an O
85 B
- I
kDa I
protein I
, O
designated O
BASH B
( O
B B
cell I
adaptor I
containing I
SH2 I
domain I
) O
, O
that O
contains O
N B
- I
terminal I
acidic I
domains I
with O
SH2 B
domain I
- I
binding I
phosphotyrosine I
- I
based I
motifs I
, O
a O
proline B
- I
rich I
domain I
, O
and O
a O
C B
- I
terminal I
SH2 I
domain I
. O

The O
mRNA O
levels O
for O
fkhrl1 B
is O
elevated O
in O
T O
helper O
- O
induced O
lymphocytes O
in O
comparison O
to O
PHA O
- O
stimulated O
T O
lymphocytes O
. O

Further O
characterization O
of O
FKHRL1 B
and O
its O
related O
family O
members O
should O
shed O
light O
on O
the O
transcriptional O
mechanisms O
of O
this O
fork B
head I
gene I
subfamily I
and O
their O
role O
in O
T O
helper O
cell O
differentiation O
and O
regulation O
of O
cell O
growth O
. O

At O
the O
same O
time O
there O
was O
no O
change O
in O
the O
level O
of O
expression O
of O
the O
cell B
surface I
antigenes I
CD33 B
, O
CD34 B
, O
CD45 B
, O
CD71 B
and O
glycophorin B
A I
. O

Regulation O
of O
PAK O
activation O
and O
the O
T O
cell O
cytoskeleton O
by O
the O
linker B
protein I
SLP B
- I
76 I
. O

The O
Duffy B
protein I
is O
a O
receptor O
for O
the O
Plasmodium B
vivax I
erythrocyte I
- I
binding I
protein I
and O
is O
also O
a O
receptor O
for O
various O
chemokines B
( O
thus O
renamed O
Duffy B
Antigen I
Receptor I
for I
Chemokines I
[ O
DARC B
] O
) O
. O

We O
first O
demonstrate O
, O
in O
human O
and O
mouse O
intraspecies O
hybrids O
, O
the O
coordinate O
suppression O
of O
MHC B
class I
II I
, O
Ii B
( O
invariant B
chain I
) O
and O
HLA B
- I
DM I
gene I
transcription O
, O
and O
the O
release O
of O
the O
silencing O
by O
the O
addition O
of O
interferon B
gamma I
. O

These O
stimuli O
also O
induced O
the O
stress O
- O
activated O
kinase O
pathway O
( O
SAPK B
/ B
JNK I
) O
, O
which O
was O
required O
for O
the O
maximal O
induction O
of O
apoptosis O
. O

Surface O
marker O
analysis O
showed O
that O
HMBA O
- O
induced O
cells O
expressed O
reduced O
levels O
of O
glycophorin B
A I
, O
CD5 B
, O
CD7 B
and O
CD11b B
. O

Somewhat O
unexpectedly O
, O
the O
constitutive O
p21ras B
activity O
did O
not O
cause O
an O
increased O
DNA O
binding O
of O
transcription B
factors I
PEA1 B
( O
AP1 B
) O
, O
PEA3 B
, O
Oct B
- I
2 I
or O
NF B
- I
kB I

We O
have O
earlier O
found O
that O
in O
Jurkat O
cells O
activation O
of O
protein B
kinase I
C I
( O
PKC B
) O
enhances O
the O
cyclic O
adenosine O
monophosphate O
( O
cAMP O
) O
accumulation O
induced O
by O
adenosine O
receptor O
stimulation O
or O
activation O
of O
Gs B
. O

One O
gene O
of O
interest O
is O
the O
glycoprotein B
IIb I
( I
GPIIb I
) I
gene I
; O
GPIIb B
, O
the O
alpha B
subunit I
of O
the O
platelet B
cytoadhesin I
GPIIb I
- I
IIIa I
, O
is O
produced O
in O
megakaryocytes O
at O
an O
early O
stage O
of O
the O
differentiation O
, O
whereas O
the O
other O
subunit O
of O
this O
complex O
, O
GPIIIa B
, O
is O
expressed O
in O
other O
cells O
. O

Five O
T O
- O
cell O
clones O
specific O
for O
a O
T B
- I
cell I
epitope I
located O
at O
the O
carboxyterminal B
region I
of O
HBxAg B
were O
established O
and O
found O
to O
belong O
to O
the O
CD2 O
/ O
CD4 O
- O
positive O
, O
CD8 O
- O
negative O
subtype O
. O

From O
information O
available O
in O
the O
literature O
on O
the O
substrate O
specificity O
of O
the O
three O
enzymes B
, O
it O
is O
clear O
that O
a O
cysteine O
is O
not O
accepted O
in O
any O
of O
the O
S2 B
, I
S1 I
, I
S1 I
' I
, I
and I
S2 I
' I
subsites I
of O
cathepsin B
B I
and I
L I
, O
and O
not O
in O
the O
S1 B
and O
S1 B
' I
subsites O
of O
cathepsin B
D I
. O

The O
fusion B
cDNA I
results O
from O
an O
interstitial O
deletion O
between O
a O
previously O
unknown B
locus I
, O
SIL B
( O
SCL B
interrupting I
locus I
) O
, O
and O
the O
5 B
' I
untranslated I
region I
of O
SCL B
. O

Two O
distinct O
forms O
of O
active B
transcription I
factor I
CREB I
( O
cAMP B
response I
element I
binding I
protein I
) O
. O

Transcription B
factor I
IID I
( O
TFIID B
) O
binds O
to O
the O
TATA B
box I
promoter I
element I
and O
regulates O
the O
expression O
of O
most O
eukaryotic B
genes I
transcribed O
by O
RNA B
polymerase I
II I
. O

As O
this O
phosphorylation O
was O
independent O
of O
protein B
kinase I
C I
activity O
, O
we O
tested O
whether O
a O
calcium B
/ I
calmodulin I
- I
dependent I
protein I
kinase I
( O
CaM B
kinase I
) O
might O
phosphorylate O
the O
Ets B
- I
1 I
protein I
after O
elevation O
of O
intracellular O
free O
calcium O
concentrations O
. O

